Every 10-Q that OneMedNet Corp (ONMD) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow ONMD and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ONMD filings page.
OneMedNet Corporation, a healthcare software company focused on real-world data from medical imaging, reported continued operating losses and liquidity pressure for the quarter and six months ended June 30, 2026. Revenue was modest but growing, with quarterly revenue of $0.3 million, up from $0.2 million a year earlier, driven by higher data delivery volumes on its iRWD platform after decommissioning its legacy BEAM subscription product.
Despite this growth, the company posted a quarterly gross loss of $0.6 million, an operating loss of $2.3 million, and a six‑month net loss of $4.6 million. Cash and cash equivalents were only $0.4 million against total liabilities of $4.9 million and a stockholders’ deficit of $3.5 million, and management states that these conditions raise substantial doubt about its ability to continue as a going concern.
The company funded operations through related‑party equity subscriptions and a 2024 Standby Equity Purchase Agreement, issuing additional shares and expanding its share count to 59.3 million common shares outstanding as of August 11, 2026. It exited all Bitcoin holdings, recorded gains from warrant and SEPA derivative remeasurements, and in July 2026 entered a new $25.0 million SEPA with Yorkville. OneMedNet also discloses noncompliance with Nasdaq’s $1.00 minimum bid price requirement and ongoing material weaknesses in internal controls over financial reporting.
OneMedNet Corporation reported Q1 2026 revenue of $96,000 and a net loss of $2.5 million, reflecting a 30% revenue decline and wider losses versus Q1 2025. Cost of revenue of $0.5 million produced a negative gross margin, and operating expenses remained high at $2.2 million.
Cash and cash equivalents fell to $233,000 as of March 31, 2026, against $5.6 million of total liabilities and a stockholders’ deficit of $4.1 million. Management disclosed substantial doubt about the company’s ability to continue as a going concern and is relying on equity financing, including a Yorkville SEPA draw and related-party subscriptions.
The company holds a small Bitcoin position, realizes gains and losses from sales, and received an April 2026 Nasdaq notice for noncompliance with the $1.00 minimum bid price rule, with a grace period to regain compliance.
OneMedNet Corporation reported Q3 2025 results with total revenue of $177K (vs. $142K a year ago), driven by web imaging revenue of $177K as subscription revenue was $0. Gross margin was -$222K, and operating loss was $2.24M. Net loss for the quarter was $741K (vs. $2.06M loss a year ago).
For the nine months, revenue was $468K (vs. $617K in 2024). Despite a $6.59M operating loss, the company recorded $339K net income, primarily from non-operating items, including gains on troubled debt restructurings. Cash was $149K with $600K in Bitcoin (5 units) as of September 30, 2025; total assets were $1.51M against current liabilities of $5.01M, and stockholders’ deficit was -$3.94M. Management states these conditions raise substantial doubt about the ability to continue as a going concern.
The company raised capital through June and August 2025 equity sales and related-party subscriptions, converted debt to equity (PIPE Notes and loan extensions), and repaid the Yorkville note after several conversions. Shares outstanding were 51,005,205 as of November 7, 2025.